Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Combined intervention of quarantine, school closure, workplace distancing projected to be most effective.
A long-acting therapy may be noninferior to the current daily oral antiretroviral therapy (ART) in maintaining viral suppression in the treatment of HIV-1 infection.
The American Heart Association released interim guidance on resuscitation care in patients with known or suspected COVID-19.
Samples from goggles, N95 respirators, shoes of 30 health care workers were negative for SARS-CoV-2.
With increasing numbers of countries implementing the use of the rotavirus vaccine, rotavirus and acute gastroenteritis hospitalizations and mortalities continue to show a sustained reduction.
The National Institutes of Health has launched a new website with educational resources for hospital employees, emergency first responders, and other workers at risk for exposure to COVID-19.
Baloxavir inhibits the endonuclease activity of the polymerase acidic protein resulting in inhibition of influenza virus replication.
Convalescent plasma, which is collected from patients who have recovered from COVID-19, contains antibodies to SARS-CoV-2, the virus that causes the disease.
Reduction in HIV-1 RNA level significantly greater for fostemsavir versus placebo in randomized cohort.
Current mortality rate estimates for COVID-19 may not be representative of the actual death rate.
In cases of complicated urinary tract infections (UTI) treated with multiple-dose fosfomycin, clinical resolution occurred in 2 of 3 treatment episodes.
Low expression of the HPV-related marker cyclin D1 appears to be an independent prognostic marker in Barrett high-grade dysplasia and esophageal adenocarcinoma.
The incidence of developing tuberculosis is high among exposed infants and young children.
Pulmonary function test monitoring is recommended in pediatric patients with chronic hepatitis B.
Concurrent initiation of opioid agonist therapy and HCV treatment in people who inject drugs with opioid use disorder can result in high rates of HCV cure and reduced drug use risk.
Serum HBsAg in patients with chronic hepatitis B (CHB) correlated with inhibitory receptor expression, HBV-specific CD4+ T-cell responses, and augmentation by checkpoint blockade.
A newly developed hepatocellular carcinoma risk score enables risk stratification for hepatocellular carcinoma development among patients with chronic hepatitis C infections at sustained virologic response.
Dried blood spot viral load may be more accurate and useful than plasma viral load for patients with HIV in settings with limited resources.
Buprenorphine treatments for opioid use disorder among people living with HIV demonstrated beneficial effects in terms of viral load.